Who Owns Passage Bio Stock?
NASDAQ: PASGHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 46.43%
- Held by insiders
- 7.71%
- Institutional holders
- 37
- Institutions 46.4%
- Insiders 7.7%
- Public and other 45.9%
Who owns Passage Bio stock?
Institutional investors own about 46.4% of Passage Bio's shares, spread across 37 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 7.71% of PASG.
The largest institutional holders are Lynx1 Capital Management Lp (20.94%), Vanguard Capital Management LLC (3.54%) and Balyasny Asset Management LP (3.33%). Together, the top 10 institutions control 39.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their PASG positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PASG
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Lynx1 Capital Management Lp | 673.76K | 20.94% | +8.0% |
| Vanguard Capital Management LLC | 113.96K | 3.54% | 0.0% |
| Balyasny Asset Management LP | 107.03K | 3.33% | +100.0% |
| Ikarian Capital, LLC | 99.52K | 3.09% | +46.1% |
| Yiheng Capital Management, L.P. | 86.10K | 2.68% | 0.0% |
| Renaissance Technologies, LLC | 47.89K | 1.49% | -64.2% |
| Erste Asset Management GmbH | 40.66K | 1.26% | -52.3% |
| Geode Capital Management, LLC | 37.03K | 1.15% | -10.5% |
| Verdad Advisers, LP | 30.73K | 0.95% | +38.9% |
| Boothbay Fund Management, LLC | 28.44K | 0.88% | +50.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PASG
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 78.76K | 2.45% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 35.20K | 1.09% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 17.13K | 0.53% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 6.43K | 0.20% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 4.78K | 0.15% |
| LINCOLN Varbl INSURANCE Prod. TRT-LVIP Dimensional U.S. Core Eqy. 2 Fd | 2.02K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 1.27K | 0.04% |
| Dimensional ETF Trust-Dimensional US Core Equity 2 ETF | 792 | 0.02% |
| Master Investment Portfolio-Diversified Equity Alpha Master Portfolio | 504 | 0.02% |
| Guggenheim Active Allocation Fund | 11 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Passage Bio?
Lynx1 Capital Management Lp is the largest institutional shareholder of PASG, owning 20.94% of shares outstanding (673.76K shares) as of its latest 13F filing.
What percentage of Passage Bio is owned by institutions?
Institutions own about 46.4% of PASG shares and 50.3% of the public float.
How much of Passage Bio do insiders own?
Insiders, such as officers and directors, own about 7.71% of PASG shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.